ArticleThe Journal of clinical investigation2021

Seasonal coronavirus-specific B cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19.

Muriel Aguilar-Bretones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.